1. Home
  2. IDYA vs RXO Comparison

IDYA vs RXO Comparison

Compare IDYA & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$31.03

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo RXO Inc.

RXO

RXO Inc.

N/A

Current Price

$27.63

Market Cap

4.0B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
RXO
Founded
2015
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.0B
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
IDYA
RXO
Price
$31.03
$27.63
Analyst Decision
Strong Buy
Hold
Analyst Count
16
18
Target Price
★ $51.54
$29.83
AVG Volume (30 Days)
986.4K
★ 3.7M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
★ 72.81
EPS
N/A
★ N/A
Revenue
$218,710,000.00
★ $5,742,000,000.00
Revenue This Year
N/A
$21.35
Revenue Next Year
$216.42
$10.54
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 3024.43
26.20
52 Week Low
$26.81
$10.43
52 Week High
$42.68
$29.90

Technical Indicators

Market Signals
Indicator
IDYA
RXO
Relative Strength Index (RSI) 33.78 54.40
Support Level $29.74 $27.26
Resistance Level $35.44 $29.05
Average True Range (ATR) 1.53 0.55
MACD -0.21 -0.35
Stochastic Oscillator 4.75 17.02

Price Performance

Historical Comparison
IDYA
RXO

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About RXO RXO Inc.

RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.

Share on Social Networks: